Reported about 2 months ago
Medicare has successfully negotiated lower prices for ten high-cost medications set to take effect in 2026, including drugs like Stelara, Xarelto, and Eliquis. This effort is expected to save the Medicare program $6 billion and provide $1.5 billion in savings to beneficiaries. Dr. Meena Seshamani from the CMS emphasized the inclusive negotiation process aimed at fair pricing and transparency, involving various stakeholders to improve access to essential medications.
Source: YAHOO